Open AccessOptimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing
Author(s) -
Megan Clare Craig-Kuhn,
Charleigh Granade,
Christina A Muzny,
Barbara Van Der Pol,
Rebecca Lillis,
Stephanie N. Taylor,
Norine Schmidt,
David H. Martín,
Patricia Kissinger
Publication year - 2019
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000000968
Subject(s) - medicine , trichomonas vaginalis , metronidazole , nucleic acid amplification tests , nucleic acid , cohort , gynecology , antibiotics , chlamydia trachomatis , microbiology and biotechnology , biology , biochemistry
The optimal timing for nucleic acid amplification testing (NAAT) posttreatment for Trichomonas vaginalis has not been fully established. Testing too soon posttreatment may detect remnant nucleic acid that is not from viable organisms, falsely misclassifying person as infected. The purpose of this study was to examine how long T. vaginalis nucleic acid is detectable postmetronidazole (MTZ) treatment.